Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
887
archived clinical trials in
Autism

Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated:  1/27/2016
mi
from
Bronx, NY
Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated: 1/27/2016
Montefiore Medical Center PRIME
mi
from
Bronx, NY
Click here to add this to my saved trials
Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated:  1/27/2016
mi
from
Rochester, NY
Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated: 1/27/2016
Finger Lakes Clinical Research
mi
from
Rochester, NY
Click here to add this to my saved trials
Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated:  1/27/2016
mi
from
Staten Island, NY
Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated: 1/27/2016
Richmond Behavioral Associates
mi
from
Staten Island, NY
Click here to add this to my saved trials
Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated:  1/27/2016
mi
from
Chapel Hill, NC
Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated: 1/27/2016
Chapel Hill Neurology
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated:  1/27/2016
mi
from
Columbus, OH
Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated: 1/27/2016
Ohio State University Nisonger Center
mi
from
Columbus, OH
Click here to add this to my saved trials
Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated:  1/27/2016
mi
from
Oklahoma City, OK
Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated: 1/27/2016
Cutting Edge Research Group
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated:  1/27/2016
mi
from
Gresham, OR
Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated: 1/27/2016
Cyn3rgy Research & Development
mi
from
Gresham, OR
Click here to add this to my saved trials
Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated:  1/27/2016
mi
from
Media, PA
Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated: 1/27/2016
Suburban Research Associates
mi
from
Media, PA
Click here to add this to my saved trials
Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated:  1/27/2016
mi
from
Charleston, SC
Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated: 1/27/2016
Segal Institute for Clinical Research
mi
from
Charleston, SC
Click here to add this to my saved trials
Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated:  1/27/2016
mi
from
Memphis, TN
Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated: 1/27/2016
Clinical NeuroScience Solutions, Inc.
mi
from
Memphis, TN
Click here to add this to my saved trials
Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated:  1/27/2016
mi
from
The Woodlands, TX
Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated: 1/27/2016
Family Psychiatry of the Woodlands
mi
from
The Woodlands, TX
Click here to add this to my saved trials
Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated:  1/27/2016
mi
from
Clinton, UT
Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated: 1/27/2016
Ericksen Research And Development
mi
from
Clinton, UT
Click here to add this to my saved trials
Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated:  1/27/2016
mi
from
Salt Lake City, UT
Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated: 1/27/2016
CRI Lifetree
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated:  1/27/2016
mi
from
Charlottesville, VA
Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated: 1/27/2016
University of Virginia
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated:  1/27/2016
mi
from
Herndon, VA
Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated: 1/27/2016
NeuroScience, Inc.
mi
from
Herndon, VA
Click here to add this to my saved trials
Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated:  1/27/2016
mi
from
Roanake, VA
Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated: 1/27/2016
Carilion Clinic
mi
from
Roanake, VA
Click here to add this to my saved trials
Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated:  1/27/2016
mi
from
Bothell, WA
Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated: 1/27/2016
Pacific Institute of Medical Sciences
mi
from
Bothell, WA
Click here to add this to my saved trials
Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated:  1/27/2016
mi
from
San Francisco, CA
Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated: 1/27/2016
University of California, San Francisco Medical Center
mi
from
San Francisco, CA
Click here to add this to my saved trials
Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated:  1/27/2016
mi
from
Baltimore, MD
Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated: 1/27/2016
Kennedy Krieger Institute
mi
from
Baltimore, MD
Click here to add this to my saved trials
Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated:  1/27/2016
mi
from
Cleveland, OH
Lurasidone Pediatric Autism Study
A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder
Status: Enrolling
Updated: 1/27/2016
University Hospitals at Case Medical Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Shared Decision Making to Improve Care and Outcomes for Children With Autism
Shared Decision Making to Improve Care and Outcomes for Children With Autism
Status: Enrolling
Updated:  2/4/2016
mi
from
Cincinnati, OH
Shared Decision Making to Improve Care and Outcomes for Children With Autism
Shared Decision Making to Improve Care and Outcomes for Children With Autism
Status: Enrolling
Updated: 2/4/2016
Cincinnati Children's Medical Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
A Study of Memantine Hydrochloride (Namenda®) for Cognitive and Behavioral Impairment in Adults With Autism Spectrum Disorders
A Study of Memantine Hydrochloride (Namenda®) for Cognitive and Behavioral Impairment in Adults With Autism Spectrum Disorders
Status: Enrolling
Updated:  2/26/2016
mi
from
Boston, MA
A Study of Memantine Hydrochloride (Namenda®) for Cognitive and Behavioral Impairment in Adults With Autism Spectrum Disorders
A Study of Memantine Hydrochloride (Namenda®) for Cognitive and Behavioral Impairment in Adults With Autism Spectrum Disorders
Status: Enrolling
Updated: 2/26/2016
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Lurasidone Pediatric Pharmacokinetics Study
A Phase 1 Open-Label, Multicenter, Single and Multiple Ascending Dose Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Lurasidone in Subjects 6 to 17 Years Old With Schizophrenia Spectrum, Bipolar Spectrum, Autistic Spectrum Disorder, or Other Psychiatric Disorders
Status: Enrolling
Updated:  3/10/2016
mi
from
Little Rock, AR
Lurasidone Pediatric Pharmacokinetics Study
A Phase 1 Open-Label, Multicenter, Single and Multiple Ascending Dose Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Lurasidone in Subjects 6 to 17 Years Old With Schizophrenia Spectrum, Bipolar Spectrum, Autistic Spectrum Disorder, or Other Psychiatric Disorders
Status: Enrolling
Updated: 3/10/2016
Woodland International Research Group, Inc.
mi
from
Little Rock, AR
Click here to add this to my saved trials
Lurasidone Pediatric Pharmacokinetics Study
A Phase 1 Open-Label, Multicenter, Single and Multiple Ascending Dose Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Lurasidone in Subjects 6 to 17 Years Old With Schizophrenia Spectrum, Bipolar Spectrum, Autistic Spectrum Disorder, or Other Psychiatric Disorders
Status: Enrolling
Updated:  3/10/2016
mi
from
Springdale, AR
Lurasidone Pediatric Pharmacokinetics Study
A Phase 1 Open-Label, Multicenter, Single and Multiple Ascending Dose Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Lurasidone in Subjects 6 to 17 Years Old With Schizophrenia Spectrum, Bipolar Spectrum, Autistic Spectrum Disorder, or Other Psychiatric Disorders
Status: Enrolling
Updated: 3/10/2016
Woodland Northwest Research, LLC
mi
from
Springdale, AR
Click here to add this to my saved trials
Lurasidone Pediatric Pharmacokinetics Study
A Phase 1 Open-Label, Multicenter, Single and Multiple Ascending Dose Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Lurasidone in Subjects 6 to 17 Years Old With Schizophrenia Spectrum, Bipolar Spectrum, Autistic Spectrum Disorder, or Other Psychiatric Disorders
Status: Enrolling
Updated:  3/10/2016
mi
from
Murrietta, CA
Lurasidone Pediatric Pharmacokinetics Study
A Phase 1 Open-Label, Multicenter, Single and Multiple Ascending Dose Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Lurasidone in Subjects 6 to 17 Years Old With Schizophrenia Spectrum, Bipolar Spectrum, Autistic Spectrum Disorder, or Other Psychiatric Disorders
Status: Enrolling
Updated: 3/10/2016
World Wide Research Centers Inc.
mi
from
Murrietta, CA
Click here to add this to my saved trials
Lurasidone Pediatric Pharmacokinetics Study
A Phase 1 Open-Label, Multicenter, Single and Multiple Ascending Dose Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Lurasidone in Subjects 6 to 17 Years Old With Schizophrenia Spectrum, Bipolar Spectrum, Autistic Spectrum Disorder, or Other Psychiatric Disorders
Status: Enrolling
Updated:  3/10/2016
mi
from
Atlanta, GA
Lurasidone Pediatric Pharmacokinetics Study
A Phase 1 Open-Label, Multicenter, Single and Multiple Ascending Dose Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Lurasidone in Subjects 6 to 17 Years Old With Schizophrenia Spectrum, Bipolar Spectrum, Autistic Spectrum Disorder, or Other Psychiatric Disorders
Status: Enrolling
Updated: 3/10/2016
Atlanta Center for Medical Research
mi
from
Atlanta, GA
Click here to add this to my saved trials
Lurasidone Pediatric Pharmacokinetics Study
A Phase 1 Open-Label, Multicenter, Single and Multiple Ascending Dose Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Lurasidone in Subjects 6 to 17 Years Old With Schizophrenia Spectrum, Bipolar Spectrum, Autistic Spectrum Disorder, or Other Psychiatric Disorders
Status: Enrolling
Updated:  3/10/2016
mi
from
Cincinnati, OH
Lurasidone Pediatric Pharmacokinetics Study
A Phase 1 Open-Label, Multicenter, Single and Multiple Ascending Dose Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Lurasidone in Subjects 6 to 17 Years Old With Schizophrenia Spectrum, Bipolar Spectrum, Autistic Spectrum Disorder, or Other Psychiatric Disorders
Status: Enrolling
Updated: 3/10/2016
University of Cincinnati, Dept. of Psychiatry & Behavioral Neuroscience
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Lurasidone Pediatric Pharmacokinetics Study
A Phase 1 Open-Label, Multicenter, Single and Multiple Ascending Dose Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Lurasidone in Subjects 6 to 17 Years Old With Schizophrenia Spectrum, Bipolar Spectrum, Autistic Spectrum Disorder, or Other Psychiatric Disorders
Status: Enrolling
Updated:  3/10/2016
mi
from
Philadelphia, PA
Lurasidone Pediatric Pharmacokinetics Study
A Phase 1 Open-Label, Multicenter, Single and Multiple Ascending Dose Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Lurasidone in Subjects 6 to 17 Years Old With Schizophrenia Spectrum, Bipolar Spectrum, Autistic Spectrum Disorder, or Other Psychiatric Disorders
Status: Enrolling
Updated: 3/10/2016
CRI Worldwide, LLC
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Lurasidone Pediatric Pharmacokinetics Study
A Phase 1 Open-Label, Multicenter, Single and Multiple Ascending Dose Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Lurasidone in Subjects 6 to 17 Years Old With Schizophrenia Spectrum, Bipolar Spectrum, Autistic Spectrum Disorder, or Other Psychiatric Disorders
Status: Enrolling
Updated:  3/10/2016
mi
from
Orem, UT
Lurasidone Pediatric Pharmacokinetics Study
A Phase 1 Open-Label, Multicenter, Single and Multiple Ascending Dose Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Lurasidone in Subjects 6 to 17 Years Old With Schizophrenia Spectrum, Bipolar Spectrum, Autistic Spectrum Disorder, or Other Psychiatric Disorders
Status: Enrolling
Updated: 3/10/2016
Aspen Clinical Research, LLC
mi
from
Orem, UT
Click here to add this to my saved trials
Lurasidone Pediatric Pharmacokinetics Study
A Phase 1 Open-Label, Multicenter, Single and Multiple Ascending Dose Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Lurasidone in Subjects 6 to 17 Years Old With Schizophrenia Spectrum, Bipolar Spectrum, Autistic Spectrum Disorder, or Other Psychiatric Disorders
Status: Enrolling
Updated:  3/10/2016
mi
from
Ft. Lauderdale, FL
Lurasidone Pediatric Pharmacokinetics Study
A Phase 1 Open-Label, Multicenter, Single and Multiple Ascending Dose Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Lurasidone in Subjects 6 to 17 Years Old With Schizophrenia Spectrum, Bipolar Spectrum, Autistic Spectrum Disorder, or Other Psychiatric Disorders
Status: Enrolling
Updated: 3/10/2016
Segal Institute for Clinical Research
mi
from
Ft. Lauderdale, FL
Click here to add this to my saved trials
Lurasidone Pediatric Pharmacokinetics Study
A Phase 1 Open-Label, Multicenter, Single and Multiple Ascending Dose Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Lurasidone in Subjects 6 to 17 Years Old With Schizophrenia Spectrum, Bipolar Spectrum, Autistic Spectrum Disorder, or Other Psychiatric Disorders
Status: Enrolling
Updated:  3/10/2016
mi
from
South Miami, FL
Lurasidone Pediatric Pharmacokinetics Study
A Phase 1 Open-Label, Multicenter, Single and Multiple Ascending Dose Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Lurasidone in Subjects 6 to 17 Years Old With Schizophrenia Spectrum, Bipolar Spectrum, Autistic Spectrum Disorder, or Other Psychiatric Disorders
Status: Enrolling
Updated: 3/10/2016
Miami Children's Hospital
mi
from
South Miami, FL
Click here to add this to my saved trials
Lurasidone Pediatric Pharmacokinetics Study
A Phase 1 Open-Label, Multicenter, Single and Multiple Ascending Dose Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Lurasidone in Subjects 6 to 17 Years Old With Schizophrenia Spectrum, Bipolar Spectrum, Autistic Spectrum Disorder, or Other Psychiatric Disorders
Status: Enrolling
Updated:  3/10/2016
mi
from
Cleveland, OH
Lurasidone Pediatric Pharmacokinetics Study
A Phase 1 Open-Label, Multicenter, Single and Multiple Ascending Dose Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Lurasidone in Subjects 6 to 17 Years Old With Schizophrenia Spectrum, Bipolar Spectrum, Autistic Spectrum Disorder, or Other Psychiatric Disorders
Status: Enrolling
Updated: 3/10/2016
University Hospitals at Case Medical Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Acupressure and Acupuncture as an Intervention With Children With Autism II
Investigating the Use of Acupressure and Acupuncture With Children With Autism II
Status: Enrolling
Updated:  3/21/2016
mi
from
Baltimore, MD
Acupressure and Acupuncture as an Intervention With Children With Autism II
Investigating the Use of Acupressure and Acupuncture With Children With Autism II
Status: Enrolling
Updated: 3/21/2016
Kennedy Krieger Institute
mi
from
Baltimore, MD
Click here to add this to my saved trials
Examining the Efficacy of Mattress Technology in Improving the Sleep Quality of Children With ASD
A Randomized, Cross-Over Study of the Efficacy of Mattress Technology in Improving the Sleep Quality of Children With ASD and Sleep Disturbances
Status: Enrolling
Updated:  4/11/2016
mi
from
Cleveland, OH
Examining the Efficacy of Mattress Technology in Improving the Sleep Quality of Children With ASD
A Randomized, Cross-Over Study of the Efficacy of Mattress Technology in Improving the Sleep Quality of Children With ASD and Sleep Disturbances
Status: Enrolling
Updated: 4/11/2016
Cleveland Clinic Center for Autism
mi
from
Cleveland, OH
Click here to add this to my saved trials
A Multi-site Double-blind Placebo-controlled Trial of Memantine Versus Placebo in Children With Autism (MEM)
A Multi-site Double-blind Placebo-controlled Trial of Memantine Versus Placebo in Children With Autism Targeting Memory and Motor Planning
Status: Enrolling
Updated:  4/12/2016
mi
from
Chicago, IL
A Multi-site Double-blind Placebo-controlled Trial of Memantine Versus Placebo in Children With Autism (MEM)
A Multi-site Double-blind Placebo-controlled Trial of Memantine Versus Placebo in Children With Autism Targeting Memory and Motor Planning
Status: Enrolling
Updated: 4/12/2016
Rush University Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
A Multi-site Double-blind Placebo-controlled Trial of Memantine Versus Placebo in Children With Autism (MEM)
A Multi-site Double-blind Placebo-controlled Trial of Memantine Versus Placebo in Children With Autism Targeting Memory and Motor Planning
Status: Enrolling
Updated:  4/12/2016
mi
from
New York, NY
A Multi-site Double-blind Placebo-controlled Trial of Memantine Versus Placebo in Children With Autism (MEM)
A Multi-site Double-blind Placebo-controlled Trial of Memantine Versus Placebo in Children With Autism Targeting Memory and Motor Planning
Status: Enrolling
Updated: 4/12/2016
Mount Sinai School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
Intranasal Oxytocin for the Treatment of Children and Adolescents With Autism Spectrum Disorders (ASD)
Intranasal Oxytocin for the Treatment of Children and Adolescents With Autism
Status: Enrolling
Updated:  4/12/2016
mi
from
Minneapolis, MN
Intranasal Oxytocin for the Treatment of Children and Adolescents With Autism Spectrum Disorders (ASD)
Intranasal Oxytocin for the Treatment of Children and Adolescents With Autism
Status: Enrolling
Updated: 4/12/2016
Univ of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Intranasal Oxytocin for the Treatment of Children and Adolescents With Autism Spectrum Disorders (ASD)
Intranasal Oxytocin for the Treatment of Children and Adolescents With Autism
Status: Enrolling
Updated:  4/12/2016
mi
from
Toronto,
Intranasal Oxytocin for the Treatment of Children and Adolescents With Autism Spectrum Disorders (ASD)
Intranasal Oxytocin for the Treatment of Children and Adolescents With Autism
Status: Enrolling
Updated: 4/12/2016
Holland Bloorview Kids Rehabilitation Hospital
mi
from
Toronto,
Click here to add this to my saved trials
Brain Connectivity in Neurodevelopmental Disorders in Response to Treatment
Characterization of Potential Biomarkers to Assess Brain Connectivity in Neurodevelopmental Disorders in Response to Treatment
Status: Enrolling
Updated:  4/14/2016
mi
from
Chapel Hill, NC
Brain Connectivity in Neurodevelopmental Disorders in Response to Treatment
Characterization of Potential Biomarkers to Assess Brain Connectivity in Neurodevelopmental Disorders in Response to Treatment
Status: Enrolling
Updated: 4/14/2016
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Investigation of Neuroserpin as an Autism Candidate Gene
Investigation of Neuroserpin as an Autism Candidate Gene
Status: Enrolling
Updated:  4/18/2016
mi
from
Syracuse, NY
Investigation of Neuroserpin as an Autism Candidate Gene
Investigation of Neuroserpin as an Autism Candidate Gene
Status: Enrolling
Updated: 4/18/2016
SUNY Upstate Medical University
mi
from
Syracuse, NY
Click here to add this to my saved trials
University of California, San Diego (UCSD) Suramin Treatment Trial for Autism
The UCSD Suramin Autism Treatment Trial
Status: Enrolling
Updated:  4/25/2016
mi
from
La Jolla, CA
University of California, San Diego (UCSD) Suramin Treatment Trial for Autism
The UCSD Suramin Autism Treatment Trial
Status: Enrolling
Updated: 4/25/2016
University of California, San Diego, School of Medicine
mi
from
La Jolla, CA
Click here to add this to my saved trials
Improving Hospitalizations for Children With ASD
Improving Hospitalizations for Children With ASD: Testing the Cost and Clinical Efficacy of Integrated Behavioral Intervention
Status: Enrolling
Updated:  4/26/2016
mi
from
Nashville, TN
Improving Hospitalizations for Children With ASD
Improving Hospitalizations for Children With ASD: Testing the Cost and Clinical Efficacy of Integrated Behavioral Intervention
Status: Enrolling
Updated: 4/26/2016
Vanderbilt University Medical Center - MEND Clinic
mi
from
Nashville, TN
Click here to add this to my saved trials
iPad Application to Treat Prosodic Deficits in Students With Communication Disorders
Handheld Technology for Speech Development in Students With Autism Spectrum Disorders
Status: Enrolling
Updated:  6/13/2016
mi
from
New Haven, CT
iPad Application to Treat Prosodic Deficits in Students With Communication Disorders
Handheld Technology for Speech Development in Students With Autism Spectrum Disorders
Status: Enrolling
Updated: 6/13/2016
Yale Child Study Center
mi
from
New Haven, CT
Click here to add this to my saved trials
Study to Assess the Janssen Autism Knowledge Engine in Participants With Autism Spectrum Disorder and in a Normally Developing Cohort
A Study to Assess the Janssen Autism Knowledge Engine in Children and Adults With Autism Spectrum Disorder and in a Normally Developing Cohort
Status: Enrolling
Updated:  11/21/2016
mi
from
Phoenix, AZ
Study to Assess the Janssen Autism Knowledge Engine in Participants With Autism Spectrum Disorder and in a Normally Developing Cohort
A Study to Assess the Janssen Autism Knowledge Engine in Children and Adults With Autism Spectrum Disorder and in a Normally Developing Cohort
Status: Enrolling
Updated: 11/21/2016
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Study to Assess the Janssen Autism Knowledge Engine in Participants With Autism Spectrum Disorder and in a Normally Developing Cohort
A Study to Assess the Janssen Autism Knowledge Engine in Children and Adults With Autism Spectrum Disorder and in a Normally Developing Cohort
Status: Enrolling
Updated:  11/21/2016
mi
from
San Francisco, CA
Study to Assess the Janssen Autism Knowledge Engine in Participants With Autism Spectrum Disorder and in a Normally Developing Cohort
A Study to Assess the Janssen Autism Knowledge Engine in Children and Adults With Autism Spectrum Disorder and in a Normally Developing Cohort
Status: Enrolling
Updated: 11/21/2016
Clinical Research Facility
mi
from
San Francisco, CA
Click here to add this to my saved trials
Study to Assess the Janssen Autism Knowledge Engine in Participants With Autism Spectrum Disorder and in a Normally Developing Cohort
A Study to Assess the Janssen Autism Knowledge Engine in Children and Adults With Autism Spectrum Disorder and in a Normally Developing Cohort
Status: Enrolling
Updated:  11/21/2016
mi
from
New Haven, CT
Study to Assess the Janssen Autism Knowledge Engine in Participants With Autism Spectrum Disorder and in a Normally Developing Cohort
A Study to Assess the Janssen Autism Knowledge Engine in Children and Adults With Autism Spectrum Disorder and in a Normally Developing Cohort
Status: Enrolling
Updated: 11/21/2016
Clinical Research Facility
mi
from
New Haven, CT
Click here to add this to my saved trials
Study to Assess the Janssen Autism Knowledge Engine in Participants With Autism Spectrum Disorder and in a Normally Developing Cohort
A Study to Assess the Janssen Autism Knowledge Engine in Children and Adults With Autism Spectrum Disorder and in a Normally Developing Cohort
Status: Enrolling
Updated:  11/21/2016
mi
from
Worcester, MA
Study to Assess the Janssen Autism Knowledge Engine in Participants With Autism Spectrum Disorder and in a Normally Developing Cohort
A Study to Assess the Janssen Autism Knowledge Engine in Children and Adults With Autism Spectrum Disorder and in a Normally Developing Cohort
Status: Enrolling
Updated: 11/21/2016
Clinical Research Facility
mi
from
Worcester, MA
Click here to add this to my saved trials
Study to Assess the Janssen Autism Knowledge Engine in Participants With Autism Spectrum Disorder and in a Normally Developing Cohort
A Study to Assess the Janssen Autism Knowledge Engine in Children and Adults With Autism Spectrum Disorder and in a Normally Developing Cohort
Status: Enrolling
Updated:  11/21/2016
mi
from
Toms River, NJ
Study to Assess the Janssen Autism Knowledge Engine in Participants With Autism Spectrum Disorder and in a Normally Developing Cohort
A Study to Assess the Janssen Autism Knowledge Engine in Children and Adults With Autism Spectrum Disorder and in a Normally Developing Cohort
Status: Enrolling
Updated: 11/21/2016
Clinical Research Facility
mi
from
Toms River, NJ
Click here to add this to my saved trials
Study to Assess the Janssen Autism Knowledge Engine in Participants With Autism Spectrum Disorder and in a Normally Developing Cohort
A Study to Assess the Janssen Autism Knowledge Engine in Children and Adults With Autism Spectrum Disorder and in a Normally Developing Cohort
Status: Enrolling
Updated:  11/21/2016
mi
from
Orangeburg, NY
Study to Assess the Janssen Autism Knowledge Engine in Participants With Autism Spectrum Disorder and in a Normally Developing Cohort
A Study to Assess the Janssen Autism Knowledge Engine in Children and Adults With Autism Spectrum Disorder and in a Normally Developing Cohort
Status: Enrolling
Updated: 11/21/2016
Clinical Research Facility
mi
from
Orangeburg, NY
Click here to add this to my saved trials
Study to Assess the Janssen Autism Knowledge Engine in Participants With Autism Spectrum Disorder and in a Normally Developing Cohort
A Study to Assess the Janssen Autism Knowledge Engine in Children and Adults With Autism Spectrum Disorder and in a Normally Developing Cohort
Status: Enrolling
Updated:  11/21/2016
mi
from
Durham, NC
Study to Assess the Janssen Autism Knowledge Engine in Participants With Autism Spectrum Disorder and in a Normally Developing Cohort
A Study to Assess the Janssen Autism Knowledge Engine in Children and Adults With Autism Spectrum Disorder and in a Normally Developing Cohort
Status: Enrolling
Updated: 11/21/2016
Clinical Research Facility
mi
from
Durham, NC
Click here to add this to my saved trials